According to the Aerospace Development announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for three consecutive trading days from December 3 to December 5, 2025, which is an abnormal fluctuation. After verification, the company's recent operations and internal and external environment have been normal. No major undisclosed information that may affect the stock price has been discovered. There is no need to correct or supplement the information disclosed in the early stages, the actual controller and controlling shareholders should not disclose important undisclosed matters, and there was no trading situation in the company's stock during the period of abnormal fluctuations. The company warned that stock prices continued to rise in the short term, and there is a risk of overheating market sentiment and irrational speculation, reminding investors to invest rationally.

According to the Aerospace Development announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for three consecutive trading days from December 3 to December 5, 2025, which is an abnormal fluctuation. After verification, the company's recent operations and internal and external environment have been normal. No major undisclosed information that may affect the stock price has been discovered. There is no need to correct or supplement the information disclosed in the early stages, the actual controller and controlling shareholders should not disclose important undisclosed matters, and there was no trading situation in the company's stock during the period of abnormal fluctuations. The company warned that stock prices continued to rise in the short term, and there is a risk of overheating market sentiment and irrational speculation, reminding investors to invest rationally.